Clostridium Diagnostics Market to grow at a CAGR of 13.69% from 2022 to 2027, Driven by the growing prevalence of CDI - Technavio

Rhea-AI Summary

The global clostridium diagnostics market is projected to expand by USD 2,148.4 million from 2022 to 2027, with a CAGR of 13.69%. This growth is largely driven by the surge in Clostridium difficile infection (CDI), particularly among the elderly population, where annual incidents in the US reach approximately 200,000. North America is expected to contribute 38% to this growth, propelled by antibiotic use and a growing aging demographic. Key trends include the development of new vaccines and advancements in immunoassays. However, challenges persist, including resource scarcity and lack of awareness in developing regions, hindering widespread diagnosis and treatment.

Positive

• Projected market growth of USD 2,148.4 million from 2022 to 2027.
• CAGR of 13.69%, indicating strong market expansion.
• Significant contributions from the immunoassays segment due to technological advancements.
• North America expected to drive 38% of market growth, supported by a large aging population.

Negative

• Resource scarcity and limited awareness in developing countries about CDI diagnosis.
• Physicians in Asia have poor knowledge of CDI, underestimating its impact.

NEW YORK, March 27, 2023 /PRNewswire/ -- The global clostridium diagnostics market  size is estimated to grow by USD 2,148.4 million from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 13.69% during the forecast period. The increasing prevalence of CDI is a major factor fueling the growth of the global clostridium diagnostics market. CDI has dramatically increased in frequency and severity over the past three decades worldwide, which is a major driving factor for the growth of the market. There has been a significant shift in the epidemiology of CDI infection, as evident from an uprise in incidence and severity, which is disproportionately more common in older patients. In some areas of the US, the overall CDI incidents have risen to the point where it has surpassed rates of methicillin-resistant S. aureus infections. In a recent report on threats from antibiotic resistance in the US, the Centers for Disease Control and Prevention designated CDI as an urgent threat. It highlights the need for quick and decisive action to stop this infection. 

For more insights on the historic market data (2017 to 2021) and forecast market size (2023 to 2027) - Request a sample report

What's New?

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
• Global competitiveness and key competitor positions 
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial  - buy the report!

Clostridium Diagnostics Market - Segmentation Assessment
Segment Overview
Technavio has segmented the market based on technology (immunoassays and molecular diagnostics), product (clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium tetani, and clostridium sordellii), end-user (hospitals, independent laboratories, and physicians clinics), and geography (North America, Europe, Asia, and Rest of World (ROW)).

• The market share growth by the immunoassays segment will be significant for the market growth during the forecast period. Immunoassays are biochemical tests that use antibody-antigen interactions to determine the presence or concentration of a particular chemical like a toxin or hormone, in a solution. The practice of immunoassays is expected to continue to increase during the forecast period. This is due to technological advancements, cost-effectiveness, and the rapid analysis of immunoassays. Hence, such factors will drive the growth of the immunoassays segment in the global clostridium diagnostics market during the forecast period. 

Geography Overview
By geography, the global clostridium diagnostics market is segmented into North America, Europe, Asia, and Rest of World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global clostridium diagnostics market.

• North America is estimated to contribute to 38% of the growth of the global market during the forecast period. The growth can be attributed to the common use of antibiotics in the US. The growth in the prevalence of clostridium-related diseases in the region will drive the growth of the market during the forecast period. For instance, every year, in a hospital or care setting, about 200,000 people in the US contract CDI. Because CDI is commonly prevalent among the ageing population, the growth of the ageing population in the region will drive the growth of the global clostridium market in North America during the forecast period. 

Insights on the market contribution of various segments including country and region wise, historic (2017 to 2021) and forecast market size (2023 to 2027) - Download a Sample Report

Clostridium Diagnostics Market – Market Dynamics

Leading trends influencing the market 

The development of new vaccines is the major trend in the global clostridium diagnostics market. The rising incidence of clostridium has encouraged vendors to develop vaccines preventing clostridium-related diseases. Vaccines provide long-term protection against clostridium, with various vaccines for clostridium in different phases of development. Vaccines are designed to prevent clostridium and are cost-effective and can be used to prevent the recurrence of CDI. Hence, with the growing demand for clostridium-related vaccines from end-users, vendors are launching new vaccines. 

Major challenges hindering the market growth

The scarcity of resources and lack of awareness in developing countries is a major challenge impeding the growth of the global clostridium diagnostics market. Researchers looking at the burden of CDI in resource-limited settings noted that clinicians in developing and underdeveloped regions are much less likely to consider CDI as a diagnosis in patients presenting with community or hospital-acquired diarrhea, which is in contrast to resource-rich settings such as North America and Europe, where clinicians usually order testing for CDI (even in patients with very mild diarrhea). Furthermore, according to a recent medical survey, physicians in Asia have poor knowledge of CDI and underestimate its contribution to antibiotic-associated disease and recurrence rates. 

Insights on market drivers, trends, & challenges, historic period(2017 to 2021) and forecast period(2023 to 2027)- Request a sample report!

What are the key data covered in this Clostridium Diagnostics Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the clostridium diagnostics market between 2023 and 2027
• Precise estimation of the size of the clostridium diagnostics market and its contribution to the market with a focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the clostridium diagnostics market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of clostridium diagnostics market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

The rheumatoid arthritis diagnostic devices market size is expected to increase by USD 146.54 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.55%. One of the major factors fueling the rheumatoid arthritis diagnostic devices market is the increasing number of rheumatoid arthritis cases.

The dermatology diagnostic devices market has the potential to grow by USD 10.55 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 12.54%. The increase in the prevalence of melanoma and autoimmune skin diseases is estimated to fuel the growth of the dermatology diagnostic devices market size.

Clostridium Diagnostics Market Scope
Report Coverage	Details
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 13.69%
Market growth 2023-2027	USD 2,148.4 million
Market structure	Fragmented
YoY growth 2022-2023 (%)	12.67
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 38%
Key countries	US, Canada, Germany, UK, and China, Canada, Mexico, Italy,Spain, India, Japan, Australia, and South Korea
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	AstraZeneca Plc, Beckman Coulter Inc., Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, F. Hoffmann La Roche Ltd., Ferring BV, Fujirebio Holdings Inc., Hologic Inc., Huvepharma, Meridian Bioscience Inc., Novartis AG, Olympus Corp., Pfizer Inc., QIAGEN NV, Siemens AG, Summit Therapeutics Inc., TECHLAB Inc., Thermo Fisher Scientific Inc., and Trinity Biotech Plc
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio Health Care market reports

Table of Contents   

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 08: Executive Summary – Chart on Incremental Growth
• Exhibit 09: Executive Summary – Data Table on Incremental Growth
• Exhibit 10: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 11: Parent market
• Exhibit 12: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 13: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 14: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 15: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global clostridium diagnostics market 2017 - 2021
• Exhibit 19: Historic Market Size – Data Table on Global clostridium diagnostics market 2017 - 2021 ($ million)

• 4.2 Technology Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – Technology Segment 2017 - 2021 ($ million)

• 4.3 Product Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.4 End user Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size – End user Segment 2017 - 2021 ($ million)

• 4.5 Geography Segment Analysis 2017 - 2021
• Exhibit 23: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.6 Country Segment Analysis 2017 - 2021
• Exhibit 24: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 25: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 26: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 27: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 28: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 29: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 30: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 31: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Technology

• 6.1 Market segments 
• Exhibit 32: Chart on Technology - Market share 2022-2027 (%)
• Exhibit 33: Data Table on Technology - Market share 2022-2027 (%)

• 6.2 Comparison by Technology 
• Exhibit 34: Chart on Comparison by Technology
• Exhibit 35: Data Table on Comparison by Technology

• 6.3 Immunoassays - Market size and forecast 2022-2027
• Exhibit 36: Chart on Immunoassays - Market size and forecast 2022-2027 ($ million)
• Exhibit 37: Data Table on Immunoassays - Market size and forecast 2022-2027 ($ million)
• Exhibit 38: Chart on Immunoassays - Year-over-year growth 2022-2027 (%)
• Exhibit 39: Data Table on Immunoassays - Year-over-year growth 2022-2027 (%)

• 6.4 Molecular diagnostics - Market size and forecast 2022-2027 
• Exhibit 40: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 41: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 42: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
• Exhibit 43: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Technology 
• Exhibit 44: Market opportunity by Technology ($ million)
• Exhibit 45: Data Table on Market opportunity by Technology ($ million)

7 Market Segmentation by Product

• 7.1 Market segments 
• Exhibit 46: Chart on Product - Market share 2022-2027 (%)
• Exhibit 47: Data Table on Product - Market share 2022-2027 (%)

• 7.2 Comparison by Product 
• Exhibit 48: Chart on Comparison by Product
• Exhibit 49: Data Table on Comparison by Product

• 7.3 Clostridium difficile - Market size and forecast 2022-2027 
• Exhibit 50: Chart on Clostridium difficile - Market size and forecast 2022-2027 ($ million)
• Exhibit 51: Data Table on Clostridium difficile - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Chart on Clostridium difficile - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Clostridium difficile - Year-over-year growth 2022-2027 (%)

• 7.4 Clostridium perfringens - Market size and forecast 2022-2027 
• Exhibit 54: Chart on Clostridium perfringens - Market size and forecast 2022-2027 ($ million)
• Exhibit 55: Data Table on Clostridium perfringens - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Chart on Clostridium perfringens - Year-over-year growth 2022-2027 (%)
• Exhibit 57: Data Table on Clostridium perfringens - Year-over-year growth 2022-2027 (%)

• 7.5 Clostridium botulinum - Market size and forecast 2022-2027 
• Exhibit 58: Chart on Clostridium botulinum - Market size and forecast 2022-2027 ($ million)
• Exhibit 59: Data Table on Clostridium botulinum - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Chart on Clostridium botulinum - Year-over-year growth 2022-2027 (%)
• Exhibit 61: Data Table on Clostridium botulinum - Year-over-year growth 2022-2027 (%)

• 7.6 Clostridium tetani - Market size and forecast 2022-2027 
• Exhibit 62: Chart on Clostridium tetani - Market size and forecast 2022-2027 ($ million)
• Exhibit 63: Data Table on Clostridium tetani - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Chart on Clostridium tetani - Year-over-year growth 2022-2027 (%)
• Exhibit 65: Data Table on Clostridium tetani - Year-over-year growth 2022-2027 (%)

• 7.7 Clostridium sordellii - Market size and forecast 2022-2027 
• Exhibit 66: Chart on Clostridium sordellii - Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Data Table on Clostridium sordellii - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Chart on Clostridium sordellii - Year-over-year growth 2022-2027 (%)
• Exhibit 69: Data Table on Clostridium sordellii - Year-over-year growth 2022-2027 (%)

• 7.8 Market opportunity by Product 
• Exhibit 70: Market opportunity by Product ($ million)
• Exhibit 71: Data Table on Market opportunity by Product ($ million)

8 Market Segmentation by End-user

• 8.1 Market segments 
• Exhibit 72: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 73: Data Table on End-user - Market share 2022-2027 (%)

• 8.2 Comparison by End-user 
• Exhibit 74: Chart on Comparison by End-user
• Exhibit 75: Data Table on Comparison by End-user

• 8.3 Hospitals - Market size and forecast 2022-2027
• Exhibit 76: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 79: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)

• 8.4 Independent laboratories - Market size and forecast 2022-2027 
• Exhibit 80: Chart on Independent laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Data Table on Independent laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Chart on Independent laboratories - Year-over-year growth 2022-2027 (%)
• Exhibit 83: Data Table on Independent laboratories - Year-over-year growth 2022-2027 (%)

• 8.5 Physicians clinics - Market size and forecast 2022-2027 
• Exhibit 84: Chart on Physicians clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Data Table on Physicians clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Chart on Physicians clinics - Year-over-year growth 2022-2027 (%)
• Exhibit 87: Data Table on Physicians clinics - Year-over-year growth 2022-2027 (%)

• 8.6 Market opportunity by End-user 
• Exhibit 88: Market opportunity by End-user ($ million)
• Exhibit 89: Data Table on Market opportunity by End-user ($ million)

9 Customer Landscape

• 9.1 Customer landscape overview 
• Exhibit 90: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

• 10.1 Geographic segmentation 
• Exhibit 91: Chart on Market share by geography 2022-2027 (%)
• Exhibit 92: Data Table on Market share by geography 2022-2027 (%)

• 10.2 Geographic comparison 
• Exhibit 93: Chart on Geographic comparison
• Exhibit 94: Data Table on Geographic comparison

• 10.3 North America - Market size and forecast 2022-2027
• Exhibit 95: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 10.4 Europe - Market size and forecast 2022-2027
• Exhibit 99: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 10.5 Asia - Market size and forecast 2022-2027
• Exhibit 103: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 10.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 107: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 10.7 US - Market size and forecast 2022-2027
• Exhibit 111: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 112: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 113: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 114: Data Table on US - Year-over-year growth 2022-2027 (%)

• 10.8 Germany - Market size and forecast 2022-2027
• Exhibit 115: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 116: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 117: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 118: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 10.9 UK - Market size and forecast 2022-2027
• Exhibit 119: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 120: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 121: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 122: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 10.10 China - Market size and forecast 2022-2027
• Exhibit 123: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 124: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 125: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 126: Data Table on China - Year-over-year growth 2022-2027 (%)

• 10.11 Canada - Market size and forecast 2022-2027
• Exhibit 127: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 128: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 129: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 130: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 10.12 Market opportunity by geography 
• Exhibit 131: Market opportunity by geography ($ million)
• Exhibit 132: Data Tables on Market opportunity by geography ($ million)

11 Drivers, Challenges, and Trends

• 11.1 Market drivers

• 11.2 Market challenges

• 11.3 Impact of drivers and challenges 
• Exhibit 133: Impact of drivers and challenges in 2022 and 2027

• 11.4 Market trends

12 Vendor Landscape

• 12.1 Overview

• 12.2 Vendor landscape 
• Exhibit 134: Overview on Criticality of inputs and Factors of differentiation

• 12.3 Landscape disruption 
• Exhibit 135: Overview on factors of disruption

• 12.4 Industry risks 
• Exhibit 136: Impact of key risks on business

13 Vendor Analysis

• 13.1 Vendors covered 
• Exhibit 137: Vendors covered

• 13.2 Market positioning of vendors 
• Exhibit 138: Matrix on vendor position and classification

• 13.3 AstraZeneca Plc 
• Exhibit 139: AstraZeneca Plc - Overview
• Exhibit 140: AstraZeneca Plc - Product / Service
• Exhibit 141: AstraZeneca Plc - Key news
• Exhibit 142: AstraZeneca Plc - Key offerings

• 13.4 Becton Dickinson and Co. 
• Exhibit 143: Becton Dickinson and Co. - Overview
• Exhibit 144: Becton Dickinson and Co. - Business segments
• Exhibit 145: Becton Dickinson and Co. - Key news
• Exhibit 146: Becton Dickinson and Co. - Key offerings
• Exhibit 147: Becton Dickinson and Co. - Segment focus

• 13.5 bioMerieux SA 
• Exhibit 148: bioMerieux SA - Overview
• Exhibit 149: bioMerieux SA - Product / Service
• Exhibit 150: bioMerieux SA - Key offerings

• 13.6 DiaSorin SpA 
• Exhibit 151: DiaSorin SpA - Overview
• Exhibit 152: DiaSorin SpA - Business segments
• Exhibit 153: DiaSorin SpA - Key news
• Exhibit 154: DiaSorin SpA - Key offerings
• Exhibit 155: DiaSorin SpA - Segment focus

• 13.7 F. Hoffmann La Roche Ltd. 
• Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus

• 13.8 Ferring BV 
• Exhibit 161: Ferring BV - Overview
• Exhibit 162: Ferring BV - Product / Service
• Exhibit 163: Ferring BV - Key offerings

• 13.9 Fujirebio Holdings Inc. 
• Exhibit 164: Fujirebio Holdings Inc. - Overview
• Exhibit 165: Fujirebio Holdings Inc. - Product / Service
• Exhibit 166: Fujirebio Holdings Inc. - Key offerings

• 13.10 Hologic Inc. 
• Exhibit 167: Hologic Inc. - Overview
• Exhibit 168: Hologic Inc. - Business segments
• Exhibit 169: Hologic Inc. - Key news
• Exhibit 170: Hologic Inc. - Key offerings
• Exhibit 171: Hologic Inc. - Segment focus

• 13.11 Huvepharma 
• Exhibit 172: Huvepharma - Overview
• Exhibit 173: Huvepharma - Product / Service
• Exhibit 174: Huvepharma - Key offerings

• 13.12 Novartis AG 
• Exhibit 175: Novartis AG - Overview
• Exhibit 176: Novartis AG - Business segments
• Exhibit 177: Novartis AG - Key offerings
• Exhibit 178: Novartis AG - Segment focus

• 13.13 Olympus Corp. 
• Exhibit 179: Olympus Corp. - Overview
• Exhibit 180: Olympus Corp. - Business segments
• Exhibit 181: Olympus Corp. - Key news
• Exhibit 182: Olympus Corp. - Key offerings
• Exhibit 183: Olympus Corp. - Segment focus

• 13.14 Pfizer Inc. 
• Exhibit 184: Pfizer Inc. - Overview
• Exhibit 185: Pfizer Inc. - Product / Service
• Exhibit 186: Pfizer Inc. - Key news
• Exhibit 187: Pfizer Inc. - Key offerings

• 13.15 QIAGEN NV 
• Exhibit 188: QIAGEN NV - Overview
• Exhibit 189: QIAGEN NV - Product / Service
• Exhibit 190: QIAGEN NV - Key news
• Exhibit 191: QIAGEN NV - Key offerings

• 13.16 Siemens AG 
• Exhibit 192: Siemens AG - Overview
• Exhibit 193: Siemens AG - Business segments
• Exhibit 194: Siemens AG - Key news
• Exhibit 195: Siemens AG - Key offerings
• Exhibit 196: Siemens AG - Segment focus

• 13.17 Thermo Fisher Scientific Inc. 
• Exhibit 197: Thermo Fisher Scientific Inc. - Overview
• Exhibit 198: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 199: Thermo Fisher Scientific Inc. - Key news
• Exhibit 200: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 201: Thermo Fisher Scientific Inc. - Segment focus

14 Appendix

• 14.1 Scope of the report

• 14.2 Inclusions and exclusions checklist
• Exhibit 202: Inclusions checklist
• Exhibit 203: Exclusions checklist

• 14.3 Currency conversion rates for US$ 
• Exhibit 204: Currency conversion rates for US$

• 14.4 Research methodology 
• Exhibit 205: Research methodology
• Exhibit 206: Validation techniques employed for market sizing
• Exhibit 207: Information sources

• 14.5 List of abbreviations 
• Exhibit 208: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/clostridium-diagnostics-market-to-grow-at-a-cagr-of-13-69-from-2022-to-2027--driven-by-the-growing-prevalence-of-cdi---technavio-301780854.html

SOURCE Technavio

FAQ

What is the projected growth of the clostridium diagnostics market from 2022 to 2027?

The clostridium diagnostics market is projected to grow by USD 2,148.4 million from 2022 to 2027.

What is the CAGR of the clostridium diagnostics market?

The clostridium diagnostics market is estimated to grow at a CAGR of 13.69% during the forecast period.

How many people in the US contract CDI annually?

Approximately 200,000 people in the US contract CDI each year.

Which region is expected to contribute the most to the clostridium diagnostics market growth?

North America is expected to contribute 38% to the growth of the clostridium diagnostics market.

What are the key trends in the clostridium diagnostics market?

Key trends include the development of new vaccines and advancements in immunoassays.

What challenges does the clostridium diagnostics market face?

Challenges include resource scarcity and a lack of awareness about CDI in developing countries.